Fundz

EpilepsyGTx raised $10M in seed funding led by UCL Technology Fund to complete the CTA-enabling nonclinical package for lead program EPY201

PRIVATEJun 24, 2024

Amount Raised

$10 Million

Round Type

Seed

LondonBiotechnologyHealth CareTherapeutics

Investors

Health Technology HoldingUCL Technology Fund

Description

EpilepsyGTx has announced a total fundraise of $10 million in seed funding led by the UCL Technology Fund, with participation from Health Technology Holding. The funds will be used to complete preclinical studies for the lead gene therapy program EPY201 and to prepare for a groundbreaking first-in-human Phase 1/2a clinical study with EPY201 in focal refractory epilepsy.

Quick answer

EpilepsyGTx raised $10 Million in a Seed round, dated June 24, 2024. Investors: Health Technology Holding and UCL Technology Fund. EpilepsyGTx is based in London, England, United Kingdom.

How much did EpilepsyGTx raise?
EpilepsyGTx raised $10 Million in a Seed round on June 24, 2024.
Who invested in EpilepsyGTx?
Health Technology Holding and UCL Technology Fund are named as investors in this round.
What does EpilepsyGTx do?
EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).
Where is EpilepsyGTx based and how big is it?
EpilepsyGTx is based in London, England, United Kingdom. Fundz records about 2 employees.
Who are the decision-makers at EpilepsyGTx?
Fundz holds 2 contacts at EpilepsyGTx. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at EpilepsyGTx, and when

A new round usually means EpilepsyGTx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day EpilepsyGTx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at EpilepsyGTx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at EpilepsyGTx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

EpilepsyGTx

Location

London, England, United Kingdom

About

EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment EpilepsyGTx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for EpilepsyGTx's next move

See what Strategic adds

EpilepsyGTx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.